Developing vaccines and therapies for emerging infectious diseases
PROVIDENT: Prepositioning Optimized Strategies for Vaccines and Immunotherapeutics against Diverse Emerging Infectious Threats
This study is working on new ways to create vaccines and treatments to help protect people from new viruses, and it's designed for anyone who wants better protection against infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-10863592 on NIH RePORTER |
What this research studies
This research aims to create flexible vaccine and antibody strategies to combat new enveloped RNA viruses. It involves collaboration among multiple institutions to develop and test these strategies, focusing on understanding how these viruses infect hosts and how to effectively stimulate the immune response. The project will utilize advanced techniques in vaccine design and testing to ensure safety and efficacy, ultimately leading to products that can be quickly manufactured and approved for use. Patients may benefit from these innovations through improved protection against emerging infectious threats.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of exposure to emerging infectious diseases caused by RNA viruses.
Not a fit: Patients who are not at risk for these specific emerging infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines and therapies that protect patients from serious emerging infectious diseases.
How similar studies have performed: Previous research has shown promise in developing vaccines and therapies for similar viral threats, indicating a potential for success in this approach.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Chandran, Kartik — Albert Einstein College of Medicine
- Study coordinator: Chandran, Kartik
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.